120 related articles for article (PubMed ID: 31762146)
1. Next-generation sequencing in salivary gland carcinoma: Targetable alterations lead to a therapeutic advantage-Multicenter experience.
Moore A; Bar Y; Maurice-Dror C; Ospovat I; Sarfaty M; Korzets Y; Goldvaser H; Gordon N; Billan S; Gutfeld O; Popovtzer A
Head Neck; 2020 Apr; 42(4):599-607. PubMed ID: 31762146
[TBL] [Abstract][Full Text] [Related]
2. Next-generation sequencing in thyroid cancers: do targetable alterations lead to a therapeutic advantage?: A multicenter experience.
Moore A; Bar Y; Maurice-Dror C; Finkel I; Goldvaser H; Dudnik E; Goldstein DA; Gordon N; Billan S; Gutfeld O; Wolf I; Popovtzer A
Medicine (Baltimore); 2021 Jun; 100(25):e26388. PubMed ID: 34160418
[TBL] [Abstract][Full Text] [Related]
3. Genomics in non-adenoid cystic group of salivary gland cancers: one or more druggable entities?
Cavalieri S; Platini F; Bergamini C; Resteghini C; Galbiati D; Bossi P; Perrone F; Tamborini E; Quattrone P; Licitra L; Locati LD; Alfieri S
Expert Opin Investig Drugs; 2019 May; 28(5):435-443. PubMed ID: 30897975
[TBL] [Abstract][Full Text] [Related]
4. Salivary gland carcinoma: Towards a more personalised approach.
Rached L; Saleh K; Casiraghi O; Even C
Cancer Treat Rev; 2024 Mar; 124():102697. PubMed ID: 38401478
[TBL] [Abstract][Full Text] [Related]
5. ALK alterations in salivary gland carcinomas.
Majewska H; Gorczyński A; Czapiewski P; Menon R; Mueller J; Lakis S; Heuckmann JM; Laco J; Gupta R; Andreasen S; Stodulski D; Iliszko M; Dziadziuszko R; Jassem J; Heukamp LC; Biernat W
Virchows Arch; 2021 May; 478(5):933-941. PubMed ID: 33237469
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive genomic profiles of metastatic and relapsed salivary gland carcinomas are associated with tumor type and reveal new routes to targeted therapies.
Ross JS; Gay LM; Wang K; Vergilio JA; Suh J; Ramkissoon S; Somerset H; Johnson JM; Russell J; Ali S; Schrock AB; Fabrizio D; Frampton G; Miller V; Stephens PJ; Elvin JA; Bowles DW
Ann Oncol; 2017 Oct; 28(10):2539-2546. PubMed ID: 28961851
[TBL] [Abstract][Full Text] [Related]
7. NCOA4-RET and TRIM27-RET Are Characteristic Gene Fusions in Salivary Intraductal Carcinoma, Including Invasive and Metastatic Tumors: Is "Intraductal" Correct?
Skálová A; Ptáková N; Santana T; Agaimy A; Ihrler S; Uro-Coste E; Thompson LDR; Bishop JA; Baněčkova M; Rupp NJ; Morbini P; de Sanctis S; Schiavo-Lena M; Vanecek T; Michal M; Leivo I
Am J Surg Pathol; 2019 Oct; 43(10):1303-1313. PubMed ID: 31162284
[TBL] [Abstract][Full Text] [Related]
8. High-throughput profiling identifies clinically actionable mutations in salivary duct carcinoma.
Ku BM; Jung HA; Sun JM; Ko YH; Jeong HS; Son YI; Baek CH; Park K; Ahn MJ
J Transl Med; 2014 Oct; 12():299. PubMed ID: 25343854
[TBL] [Abstract][Full Text] [Related]
9. A molecular guide to systemic therapy in salivary gland carcinoma.
Weaver AN; Lakritz S; Mandair D; Ulanja MB; Bowles DW
Head Neck; 2023 May; 45(5):1315-1326. PubMed ID: 36859797
[TBL] [Abstract][Full Text] [Related]
10. Oncocytic intraductal carcinoma of salivary glands: a distinct variant with TRIM33-RET fusions and BRAF V600E mutations.
Bishop JA; Nakaguro M; Whaley RD; Ogura K; Imai H; Laklouk I; Faquin WC; Sadow PM; Gagan J; Nagao T
Histopathology; 2021 Sep; 79(3):338-346. PubMed ID: 33135196
[TBL] [Abstract][Full Text] [Related]
11. Whole-Genome Sequencing of Common Salivary Gland Carcinomas: Subtype-Restricted and Shared Genetic Alterations.
Karpinets TV; Mitani Y; Liu B; Zhang J; Pytynia KB; Sellen LD; Karagiannis DT; Ferrarotto R; Futreal AP; El-Naggar AK
Clin Cancer Res; 2021 Jul; 27(14):3960-3969. PubMed ID: 34011559
[TBL] [Abstract][Full Text] [Related]
12. Frequency of next-generation sequencing, prevalence of targetable mutations and response to targeted therapies amongst patients with metastatic urothelial cancer in Ireland: a multi-centre retrospective study of real-world data.
Ronan K; Jordan E; Leonard C; McDermott R
Ir J Med Sci; 2023 Nov; ():. PubMed ID: 37947995
[TBL] [Abstract][Full Text] [Related]
13. Biomarker immunoprofile and molecular characteristics in salivary duct carcinoma: clinicopathological and prognostic implications.
Santana T; Pavel A; Martinek P; Steiner P; Grossmann P; Baněčková M; Skálová A
Hum Pathol; 2019 Nov; 93():37-47. PubMed ID: 31437521
[TBL] [Abstract][Full Text] [Related]
14. Sclerosing Polycystic "Adenosis" of Salivary Glands: A Neoplasm Characterized by PI3K Pathway Alterations More Correctly Named Sclerosing Polycystic Adenoma.
Bishop JA; Gagan J; Baumhoer D; McLean-Holden AL; Oliai BR; Couce M; Thompson LDR
Head Neck Pathol; 2020 Sep; 14(3):630-636. PubMed ID: 31605313
[TBL] [Abstract][Full Text] [Related]
15. Clinical trial of nintedanib in patients with recurrent or metastatic salivary gland cancer of the head and neck: A multicenter phase 2 study (Korean Cancer Study Group HN14-01).
Kim Y; Lee SJ; Lee JY; Lee SH; Sun JM; Park K; An HJ; Cho JY; Kang EJ; Lee HY; Kim J; Keam B; Kim HR; Lee KE; Choi MY; Lee KH; Ahn MJ
Cancer; 2017 Jun; 123(11):1958-1964. PubMed ID: 28102887
[TBL] [Abstract][Full Text] [Related]
16. Next-Generation Sequencing for Patients with Sarcoma: A Single Center Experience.
Cote GM; He J; Choy E
Oncologist; 2018 Feb; 23(2):234-242. PubMed ID: 28860410
[TBL] [Abstract][Full Text] [Related]
17. Molecular Profiling of Salivary Gland Intraductal Carcinoma Revealed a Subset of Tumors Harboring NCOA4-RET and Novel TRIM27-RET Fusions: A Report of 17 cases.
Skálová A; Vanecek T; Uro-Coste E; Bishop JA; Weinreb I; Thompson LDR; de Sanctis S; Schiavo-Lena M; Laco J; Badoual C; Santana Conceiçao T; Ptáková N; Baněčkova M; Miesbauerová M; Michal M
Am J Surg Pathol; 2018 Nov; 42(11):1445-1455. PubMed ID: 30045065
[TBL] [Abstract][Full Text] [Related]
18. Novel therapeutic targets in salivary duct carcinoma uncovered by comprehensive molecular profiling.
Gargano SM; Senarathne W; Feldman R; Florento E; Stafford P; Swensen J; Vranic S; Gatalica Z
Cancer Med; 2019 Dec; 8(17):7322-7329. PubMed ID: 31609094
[TBL] [Abstract][Full Text] [Related]
19. Identification of Fusion Genes and Targets for Genetically Matched Therapies in a Large Cohort of Salivary Gland Cancer Patients.
Lassche G; van Helvert S; Eijkelenboom A; Tjan MJH; Jansen EAM; van Cleef PHJ; Verhaegh GW; Kamping EJ; Grünberg K; van Engen-van Grunsven ACH; Ligtenberg MJL; van Herpen CML
Cancers (Basel); 2022 Aug; 14(17):. PubMed ID: 36077692
[No Abstract] [Full Text] [Related]
20. SalvGlandDx - a comprehensive salivary gland neoplasm specific next generation sequencing panel to facilitate diagnosis and identify therapeutic targets.
Freiberger SN; Brada M; Fritz C; Höller S; Vogetseder A; Horcic M; Bihl M; Michal M; Lanzer M; Wartenberg M; Borner U; Bode PK; Broglie MA; Rordorf T; Morand GB; Rupp NJ
Neoplasia; 2021 May; 23(5):473-487. PubMed ID: 33878706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
